FGF21 and metabolic dysfunction-associated steatohepatitis: As evidence shown, FGF21 is reported to prevent fatty liver formation and insulin resistance in obese mice model and numerous studies showed FGF21 analogue reduced fat mass and alleviated hyperglycaemia, insulin resistance, dyslipidaemia in NASH [13, 14].